[HTML][HTML] Repurposing sertraline sensitizes non–small cell lung cancer cells to erlotinib by inducing autophagy
Lung cancer patients treated with tyrosine kinase inhibitors (TKIs) often develop resistance.
More effective and safe therapeutic agents are urgently needed to overcome TKI resistance …
More effective and safe therapeutic agents are urgently needed to overcome TKI resistance …
[PDF][PDF] Repurposing sertraline sensitizes non–small cell lung cancer cells to erlotinib by inducing autophagy
X Jiang, Z Zhao, X Pang - pdfs.semanticscholar.org
Recent advances in scientific, technological, and managerial efforts have been made to
improve efficiency of drug discovery and development. However, the number of new the US …
improve efficiency of drug discovery and development. However, the number of new the US …
[HTML][HTML] Repurposing sertraline sensitizes non–small cell lung cancer cells to erlotinib by inducing autophagy
X Jiang, W Lu, X Shen, Q Wang, J Lv, M Liu… - JCI …, 2018 - Am Soc Clin Investig
JCI Insight - Repurposing sertraline sensitizes non–small cell lung cancer cells to erlotinib by
inducing autophagy Go to The Journal of Clinical Investigation About Editors Consulting …
inducing autophagy Go to The Journal of Clinical Investigation About Editors Consulting …
[PDF][PDF] Repurposing sertraline sensitizes non–small cell lung cancer cells to erlotinib by inducing autophagy
X Jiang, Z Zhao, X Pang - scholar.archive.org
Recent advances in scientific, technological, and managerial efforts have been made to
improve efficiency of drug discovery and development. However, the number of new the US …
improve efficiency of drug discovery and development. However, the number of new the US …
Repurposing sertraline sensitizes non-small cell lung cancer cells to erlotinib by inducing autophagy
X Jiang, W Lu, X Shen, Q Wang, J Lv, M Liu… - JCI …, 2018 - pubmed.ncbi.nlm.nih.gov
Lung cancer patients treated with tyrosine kinase inhibitors (TKIs) often develop resistance.
More effective and safe therapeutic agents are urgently needed to overcome TKI resistance …
More effective and safe therapeutic agents are urgently needed to overcome TKI resistance …
Repurposing sertraline sensitizes non-small cell lung cancer cells to erlotinib by inducing autophagy.
X Jiang, W Lu, X Shen, Q Wang, J Lv, M Liu, F Cheng… - JCI Insight, 2018 - europepmc.org
Lung cancer patients treated with tyrosine kinase inhibitors (TKIs) often develop resistance.
More effective and safe therapeutic agents are urgently needed to overcome TKI resistance …
More effective and safe therapeutic agents are urgently needed to overcome TKI resistance …
[PDF][PDF] Repurposing sertraline sensitizes non–small cell lung cancer cells to erlotinib by inducing autophagy
X Jiang, W Lu, X Shen, Q Wang, J Lv, M Liu, F Cheng… - scienceopen.com
Recent advances in scientific, technological, and managerial efforts have been made to
improve efficiency of drug discovery and development. However, the number of new the US …
improve efficiency of drug discovery and development. However, the number of new the US …
Repurposing sertraline sensitizes non-small cell lung cancer cells to erlotinib by inducing autophagy.
X Jiang, W Lu, X Shen, Q Wang, J Lv, M Liu, F Cheng… - JCI Insight, 2018 - europepmc.org
Lung cancer patients treated with tyrosine kinase inhibitors (TKIs) often develop resistance.
More effective and safe therapeutic agents are urgently needed to overcome TKI resistance …
More effective and safe therapeutic agents are urgently needed to overcome TKI resistance …
[HTML][HTML] Repurposing sertraline sensitizes non–small cell lung cancer cells to erlotinib by inducing autophagy
X Jiang, W Lu, X Shen, Q Wang, J Lv, M Liu… - JCI …, 2018 - Am Soc Clin Investig
Lung cancer patients treated with tyrosine kinase inhibitors (TKIs) often develop resistance.
More effective and safe therapeutic agents are urgently needed to overcome TKI resistance …
More effective and safe therapeutic agents are urgently needed to overcome TKI resistance …